Search
for

    Sort by

    Research 301–330 of 1000+

    1. Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata Cureus · 2025
    2. Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases Preprints.org · 2025
    3. Title Choice of treatment for severe forms of alopecia areata (case reports) Vestnik dermatologii i venerologii · 2025
    4. Ivarmacitinib stimulates hair regrowth in severe alopecia areata 2025
    5. Non-classical Congenital Adrenal Hyperplasia Presenting With Severe Androgenic Alopecia: A Case Report Cureus · 2025
    6. Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata Balkan Medical Journal · 2025
    7. Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China Journal of Investigative Dermatology · 2024
    8. Platelet-rich plasma and topical minoxidil 5% in the treatment of severe alopecia areata: Report of two cases Journal of Cutaneous and Aesthetic Surgery · 2024
    9. Combination Treatment with Methotrexate for Severe Alopecia Areata Journal of the Philippine Dermatological Society · 2024
    10. Test With Oral Administration of Clomiphene May Add to Differential Diagnosis of Severe Hyperandrogenism in Postmenopausal Women - A Case Report Brazilian Journal of Case Reports · 2024
    11. 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata Journal of the American Academy of Dermatology · 2024
    12. Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia LUTS Lower Urinary Tract Symptoms · 2024
    13. 52874 Timing of eyebrow and eyelash regrowth among subgroups of scalp responders during treatment of severe alopecia areata with baricitinib Journal of the American Academy of Dermatology · 2024
    14. Dermatologic manifestations of patients with severe and non-severe COVID-19 infection: A cross-sectional study Journal of Research in Clinical Medicine · 2024
    15. Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata JAMA Dermatology · 2024
    16. A Case of Delusional Parasitosis Secondary to Severe Iron Deficiency Anaemia in a Tertiary Care Hospital: An Area for Clinical Vigilance Journal of Psychiatry Spectrum · 2024
    17. Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panel Frontiers in medicine · 2024
    18. Review of: "A Narrative Review on the Management of Severe COVID-19 Infection Using Stem Cell-based therapies with a Focus on the Registered Clinical Trials" 2024
    19. Contemporaneous onset of systemic lupus erythematosus and severe eating disorder; neither the chicken nor the egg Journal of Paediatrics and Child Health · 2024
    20. Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients Acta dermato-venereologica · 2024
    21. Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Treated With Baricitinib: An Update Through Week 152 From BRAVE-AA2 Skin · 2023
    22. A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis Indian Dermatology Online Journal · 2023
    23. A case report of occurrence of severe alopecia areata as post-COVID-19 complication Journal of Pakistan Association of Dermatologists · 2023
    24. Pilonidal Sinus Disease is Associated with Severe Hidradenitis Suppurativa in a Spanish Cohort Acta dermato-venereologica · 2023
    25. Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data Dermatology and Therapy · 2023
    26. Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial BMC Pharmacology and Toxicology · 2023
    27. (053) Multidisciplinary Treatment of Transgender Woman with Severe Gender Dysphoria and Comorbid Psychiatric Disorders - Case Report ˜The œjournal of sexual medicine · 2023
    28. Determining Extracellular Water Effects in Mild and Severe COVID-19 Pneumonia Clinical Course by using the Bioimpedance Method Medical Bulletin of Haseki · 2023
    29. A Brazilian case of IFAP syndrome with severe congenital ichthyosis and limb malformations caused by a rare variant in MBTPS2 Revista Paulista de Pediatria · 2023
    30. Complete hair regrowth in a young male with severe atopic dermatitis and alopecia areata after dupilumab: probably more than a coincidence Portuguese journal of dermatology and venereology · 2022